Becker's Healthcare January 16, 2025
Rylee Wilson

The Drug Enforcement Administration and HHS have published a final rule to allow providers to prescribe buprenorphine through telehealth.

In a final rule published Jan. 15, the agency said it would allow providers to prescribe up to a six-month supply of buprenorphine through telehealth, without seeing a patient in person first.

The agency also published a proposed rule Jan. 15 regulating the prescribing of other controlled substances via telehealth. The agency first implemented rules allowing providers to dispense controlled substances through telehealth during the COVID-19 pandemic. Current flexibilities are in place through the end of 2025.

In September, hundreds of healthcare organizations, including the American Psychiatric Association and other mental health groups, urged the DEA to keep...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Mental Health, Patient / Consumer, Provider, Technology, Telehealth
Are third-party telehealth prescriptions of GLP-1s safe?
Unifying telemedicine efforts can help health systems succeed with virtual care
Telehealth For Menopause: Shifting Care Norms And Expanding Access
Communicating with your doctor online could cost you
Iris Telehealth Acquires innovaTel to Expand Telepsychiatry Services

Share This Article